Kautilya

8,000 Bunkers Built Along Border

About 8,000 underground bunkers have been completed for the safety of the people living along the Line of Control (LoC) and International Border (IB) in Jammu province, while directions were passed to float tenders of bunkers the construction of which have not been taken up, officials said on Sunday.

Advanced Light Helicopters Inducted at INS Dega

The induction ceremony of ‘322 Dega Flight’ was held in the presence of Vice Adm Ajendra Bahadur Singh, AVSM, VSM Flag Officer Commanding-in-Chief, Eastern Naval Command (ENC) with three indigenously built Advanced Light Helicopters (ALH) MK III helicopters flying into Naval Air Station, INS Dega on 07 Jun 21.

India Thailand Coordinated Patrol (CORPAT)

The 31stedition of India-Thailand Coordinated Patrol (Indo-Thai CORPAT) between the Indian Navyand the Royal Thai Navyis being conducted from 09 – 11 June 2021. Indian Naval Ship (INS) Saryu, an indigenously built Naval Offshore Patrol Vessel and His Majesty’s Thailand Ship (HTMS) Krabi, anOffshore Patrol Vessel, along with Dornier Maritime Patrol Aircraft from both navies are participating in the CORPAT.

Expanding Implementation of the Van Dhan Yojana in the Union Territory of Ladakh

In its series of State Level webinars that TRIFED conducted recently to review the progress of the implementation of the Van Dhan Yojana, one important outreach session was with the state teams and VDVKs of the Union Territory of Ladakh. The main focus of the session was to plan the operationalization of the sanctioned VDVKs and VDVKCs. Attendees from the UT (SIAs, SNAs, VDVKCs) were keyed up and geared to operationalize the currently sanctioned 10 VDVK cluster in the Union Territory with utmost urgency. NRLM is the implementing agency for the UT of Ladakh.

CSIR India and Laxai Life Sciences Initiate Clinical Trials of Promising Repurposed Drug Niclosamide for Treatment of Covid-19

CSIR in collaboration with Laxai Life Sciences Pvt. Ltd., has initiated Phase-II clinical trial with anti-helminitic drug Niclosamide for treatment of Covid-19. The trial is a multi-centric, phase-II, randomized, open label clinical study to evaluate efficacy, safety and tolerability of NIclosamide for the treatment of hospitalized Covid-19 patients. Niclosamide has been extensively used in past for treatment of tapeworm’s infection in adults as well as children. The safety profile of this drug has been tested over time and has been found safe for human consumption at different dose levels.

India, Australia Likely to Resume FTA Talks Soon

“Our partnership is strong, and the second wave has not dented the world’s enthusiasm in India…Like the last wave, the economic agenda will rebound,” O’Farrell said, appreciating the way the country had handled the second wave through calibrated and targeted lockdowns.